Eloxx Pharmaceuticals, Inc. (ELOX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ELOX
See up to 3 months of ELOX. The 7-day demo opens the 1M and 3M ranges and puts ELOX on your watchlist.
Start 7-day demoLatest ELOX insider trades
About Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0001035354, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector. A registration statement was filed on 7 May 2026. No offering has priced.
ELOX Form 4 activity by transaction type, last 90 days
No Form 4 activity for ELOX in the last 90 days.
ELOX insider transactions (Form 4)
4315 Form 4 filings on record, the earliest from Oct 17, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Domicilium Real Estate Fund III LP - 10% Owner | Other | common stock, $0.01 par value per share | 361,578 | - footnote F1 | - | |
| Domicilium Real Estate Fund III LP - 10% Owner | Other | Pre-funded Warrant | 238,422 | - footnote F5 | - | |
| Domicilium Real Estate Fund III LP - 10% Owner | Other | Pre-funded Warrant | 361,578 | - footnote F5 | - | |
| Domicilium Real Estate Fund III LP - 10% Owner | Other | common stock, $0.01 par value per share | 238,422 | - footnote F1 | - | |
| ||||||
| Stephen W. Webster | Grant or award | Stock Option (Right to Buy) | 13,587 | $0.00 | - | |
| Alan Edmund Walts | Grant or award | Stock Option (Right to Buy) | 8,590 | $0.00 | - | |
| Nina S. Kjellson | Grant or award | Stock Option (Right to Buy) | 13,587 | $0.00 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 328,833 | $0.00 | - | |
| Steven D. Rubin | Grant or award | Stock Option (Right to Buy) | 4,018 | $0.00 | - | |
| Domicilium Real Estate Fund III LP - 10% Owner | Other | Common Stock, $0.01 par value per share | 113,636 footnote F2 | $0.00 | - | |
| Domicilium Real Estate Fund III LP - 10% Owner | Other | Pre-funded Warrant | 113,636 footnote F2 | - footnote F5 | - | |
| ||||||
| Coastlands Capital LP - 10% Owner | Other | Common Stock | 1,250,000 | $0.00 | - | |
| Coastlands Capital LP - 10% Owner | Other | Pre-funded Warrant | 1,250,000 | $0.00 | - | |
| Steven D. Rubin | Option exercise | Common Stock | 1,875 | - footnote F1 | - | |
| Steven D. Rubin | Grant or award | Stock Option (Right to Buy) | 179,854 | $0.00 | - | |
| Steven D. Rubin | Option exercise | Restricted Stock Units | 1,875 | $0.00 | - | |
| ||||||
| Sumit Aggarwal - Officer | Option exercise | Common Stock | 196,880 | $0.00 | $20 | |
| Sumit Aggarwal - Officer | Option exercise | Common Stock | 260,946 | $0.15 | $39K | |
| Sumit Aggarwal - Officer | Derivative | Stock Option (Right to Buy) | 35,580 footnote F4 | - footnote F7 | - | |
| Sumit Aggarwal - Officer | Grant or award | Common Stock | 1,000,000 footnote F1 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Common Stock | 15,000 | - footnote F2 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 42,790 footnote F4 | $0.00 | - | |
| Sumit Aggarwal - Officer | Derivative | Stock Option (Right to Buy) | 42,790 footnote F4 | - footnote F5 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 42,790 | - footnote F5 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 35,580 | - footnote F7 | - | |
| Sumit Aggarwal - Officer | Derivative | Stock Option (Right to Buy) | 24,810 footnote F4 | - footnote F8 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 24,810 | - footnote F8 | - | |
| Sumit Aggarwal - Officer | Derivative | Stock Option (Right to Buy) | 68,700 | - footnote F10 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 68,700 | - footnote F10 | - | |
| Sumit Aggarwal - Officer | Option exercise | Stock Option (Right to Buy) | 60,390 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Stock Option (Right to Buy) | 68,700 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Stock Option (Right to Buy) | 42,790 | $0.00 | - | |
| Sumit Aggarwal - Officer | Grant or award | Stock Option (Right to Buy) | 3,597,090 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Restricted Stock Units | 15,000 | $0.00 | - | |
| Sumit Aggarwal - Officer | Option exercise | Stock Option (Right to Buy) | 260,946 | $0.00 | - | |
| ||||||
| Alan Edmund Walts | Option exercise | Common Stock | 1,875 | - footnote F1 | - | |
| Alan Edmund Walts | Grant or award | Stock Option (Right to Buy) | 395,680 | $0.00 | - | |
| Alan Edmund Walts | Option exercise | Restricted Stock Units | 1,875 | $0.00 | - | |
| ||||||
| Alan Edmund Walts - Director | Grant or award | Common Stock | 12,000 | $0.00 | - | |
| Lindsay Androski - Director | Grant or award | Common Stock | 12,000 | $0.00 | - | |
| Steven D. Rubin - Director | Grant or award | Common Stock | 12,000 | $0.00 | - | |
| Sumit Aggarwal - Officer | Grant or award | Common Stock | 165,000 | $0.00 | - | |
Item 2.02, 9.01
Item 3.02, 3.03, 5.02, 5.03, 9.01
Item 5.07
ELOX insider trading FAQ
What is the latest insider trade for ELOX?
Eloxx Pharmaceuticals, Inc. (ELOX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-17. The full record for ELOX runs to 15 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ELOX stock?
No insider purchases of ELOX were filed in the last 90 days.
How many insiders are selling ELOX stock?
No insider sales of ELOX were filed in the last 90 days.
Where can I see ELOX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ELOX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Domicilium Real Estate Fund III LP view on EDGAR
- - Stephen W. Webster view on EDGAR
- - Alan Edmund Walts view on EDGAR
- - Nina S. Kjellson view on EDGAR
- - Sumit Aggarwal view on EDGAR
- - Steven D. Rubin view on EDGAR
- - Domicilium Real Estate Fund III LP view on EDGAR
- - Coastlands Capital LP view on EDGAR
- - Steven D. Rubin view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ELOX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ELOX with a 7-day demo
- ELOX on your watchlist
- Every ELOX Form 4 filing on record
- Up to 3 months of ELOX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
